MediPoint: Viscosupplementation – Middle East and Africa Analysis and Market Forecasts

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint’s cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in the Middle East and Africa (Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered in This Report:

What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the Middle East and Africa market?

Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the Middle East and Africa viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to:

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific viscosupplementation markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies mentioned

Anika Therapeutics

Ferring Pharmaceuticals

Fidia Farmaceutici

Sanofi

Seikagaku Corporation

More than 20 others mentioned

Anika Therapeutics

Ferring Pharmaceuticals

Fidia Farmaceutici

Sanofi

Seikagaku Corporation

More than 20 others mentioned

Table of Contents

Table of Contents

1 About the Authors

1.1 Analysts

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices

1.1.2 Linda Tian, Managing ...

Table of Contents

1 About the Authors

1.1 Analysts

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices

1.1.2 Linda Tian, Managing Analyst, Medical Devices

1.1.3 Global Head of Medical Devices

2 Table of Contents

2.1 List of Tables

2.2 List of Figures

3 Executive Summary

3.1 Overview

3.2 Market Dynamics

3.3 Key Players in the Viscosupplementation Market

3.4 Viscosupplementation Market Future Outlook

4 Introduction

4.1 Catalyst

4.2 Related Reports

4.3 Upcoming Related Reports

5 Market Outlook

5.1 Procedure Trends

5.2 Pricing Trends

5.3 Revenue Trends

5.4 Company Share Analysis

6 Market Insights

6.1 Middle East and Africa

6.1.1 Israel

6.1.2 South Africa

6.1.3 Egypt, Saudi Arabia, and UAE

7 Competitive Assessment

7.1 Overview

7.2 Anika Therapeutics

7.2.1 Overview

7.2.2 Portfolio Assessment

7.2.3 Competitive Positioning

7.3 Ferring Pharmaceuticals

7.3.1 Overview

7.3.2 Portfolio Assessment

7.3.3 Competitive Positioning

7.4 Fidia Farmaceutici

7.4.1 Overview

7.4.2 Portfolio Assessment

7.4.3 Competitive Positioning

7.5 Sanofi

7.5.1 Overview

7.5.2 Portfolio Assessment

7.5.3 Competitive Positioning

7.6 Other Players

8 Appendix

8.1 Bibliography

8.2 Abbreviations

8.3 Methodology

8.3.1 Overview

8.3.2 Coverage

8.3.3 Secondary Research

8.3.4 Forecasting Methodology

8.3.5 Primary Research Summary

8.4 About MediPoint

8.5 About GlobalData

8.6 Contact Us

8.7 Disclaimer

List of tables

Table 1: Key Metrics in the Middle East and Africa Viscosupplementation Market

Table 2: Middle East and Africa Viscosupplementation Volume Forecast, 2014–2023

Table 3 ...

Table 1: Key Metrics in the Middle East and Africa Viscosupplementation Market

Table 2: Middle East and Africa Viscosupplementation Volume Forecast, 2014–2023

Table 3: Middle East and Africa Viscosupplementation Average Selling Price Forecast ($), 2014–2023

Table 4: Middle East and Africa Viscosupplementation Market Revenue Forecast ($M), 2014–2023

Table 5: Middle East and Africa Viscosupplementation Company Share Analysis, 2016

Table 6: Anika Therapeutics – Key Marketed Products Assessment

Table 7: Ferring Pharmaceuticals – Key Marketed Products Assessment

Table 8: Fidia Farmaceutici – Key Marketed Products Assessment

Table 9: Fidia Farmaceutici – Key Clinical Trials

Table 10: Sanofi – Key Marketed Products Assessment

Table 11: Summary of Other Players in the Viscosupplementation Market, 2017

List of figures

Figure 1: Viscosupplementation Sales for the Middle East and Africa, by Country, 2016 and 2023

Figure 1: Viscosupplementation Sales for the Middle East and Africa, by Country, 2016 and 2023

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports